ADVAGRAF

Found in: Austria Australia Canada Cyprus Spain France Hong Kong Lithuania Netherlands Singapore United Kingdom

Active ingredients

#
Active Ingredient
Description
1

Tacrolimus is a highly potent immunosuppressive agent. In particular, tacrolimus inhibits the formation of cytotoxic lymphocytes, which are mainly responsible for graft rejection. Tacrolimus suppresses T-cell activation and T-helper-cell dependent B-cell proliferation, as well as the formation of lymphokines (such as interleukins-2, -3, and γ-interferon) and the expression of the interleukin-2 receptor.

Medicine classification

ATC Code
Title
Class
Tacrolimus
L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AD Calcineurin inhibitors

Identifiers

Authority
Identifier(s)
Health Products and Food Branch (CA)
Identifier(s): 02296462, 02296470, 02296489, 02331667
Health Sciences Authority (SG)
Identifier(s): 14133P, 14134P, 14135P
Pharmaceutical Benefits Scheme (AU)
Identifier(s): 11907Q, 11914C, 11920J, 5299X, 5300Y, 5451X, 9664P, 9665Q, 9666R, 9681M, 9682N, 9683P
Z-Index G-Standaard PRK (NL)
Identifier(s): 96148, 96156, 96164, 96172
Base de données publique des médicaments (FR)
Identifier(s): 61604257, 61727612, 63931834, 64297436
Centro de información online de medicamentos de la AEMPS (ES)
Identifier(s): 07387014, 07387017, 07387019, 07387021, 07387024
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 116193, 116197, 116198, 116201, 140514, 140517, 156041, 196917
Valstybinė vaistų kontrolės tarnyba (LT)
Identifier(s): 1026420, 1026421, 1026422, 1026423, 1026424, 1026425, 1026426, 1037729, 1037730, 1037731, 1060782, 1060783, 1060784, 1060785, 1060786, 1060787, 1060788, 1060789, 1060790, 1060791, 1060792, 1060793, 1060794, 1068375, 1070822, 1070823
Department of Health Drug Office (HK)
Identifier(s): 56594, 56595, 56596